HealthCor Management’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-227,851
Closed -$15.2M 43
2022
Q3
$15.2M Sell
227,851
-6,279
-3% -$464K 1.9% 23
2022
Q2
$17.8M Sell
234,130
-266,270
-53% -$20.2M 1.79% 25
2022
Q1
$39.7M Buy
500,400
+392,350
+363% +$28.5M 2.65% 16
2021
Q4
$7.93M Buy
108,050
+33,050
+44% +$2.23M 0.43% 45
2021
Q3
$5.16M Buy
+75,000
New +$5.7M 0.22% 48
2021
Q2
Sell
-1,144,287
Closed -$95.4M 90
2021
Q1
$93M Buy
1,144,287
+1,124,757
+5,759% +$96M 3.29% 7
2020
Q4
$1.7M Sell
19,530
-3,050
-14% -$264K 0.07% 52
2020
Q3
$2.03M Buy
+22,580
New +$2.18M 0.08% 37
2018
Q2
Sell
-130,910
Closed -$10.9M 60
2018
Q1
$10.9M Sell
130,910
-1,219,090
-90% -$110M 0.37% 44
2017
Q4
$128M Buy
1,350,000
+751,450
+126% +$78.5M 4.16% 8
2017
Q3
$69.9M Buy
+598,550
New +$75.7M 2.34% 16
2017
Q1
Sell
-741,360
Closed -$74.3M 44
2016
Q4
$74.3M Buy
741,360
+141,360
+24% +$13.8M 4.2% 8
2016
Q3
$56.6M Buy
+600,000
New +$50.6M 3.45% 13
2016
Q1
Sell
-322,030
Closed -$34.9M 45
2015
Q4
$34.9M Buy
+322,030
New +$35.9M 2.12% 20
2013
Q3
Sell
-775,000
Closed -$17.1M 63
2013
Q2
$17.1M Buy
+775,000
New +$16.9M 1.03% 30

Other funds holding INCY

HealthCor Management's INCY Position: Q4 2022 in Review

HealthCor Management sold out of Incyte (INCY) in Q4 2022, closing a stake of 227,851 shares — an estimated $15.2M sold.

HealthCor Management first reported a position in INCY in Q2 2013 and held it in 15 quarters. The position peaked at $128M in Q4 2017. 558 funds tracked by Wall St. Rank hold INCY as of Q4 2022.

  • HealthCor Management reported no remaining Incyte position as of Q4 2022 after selling out during the quarter.
  • HealthCor Management sold 227,851 Incyte shares in Q4 2022, an estimated $15.2M.
  • HealthCor Management first reported a position in Incyte in Q2 2013 and held it in 15 quarters.
  • HealthCor Management's Incyte position peaked at $128M in Q4 2017.
  • 558 funds tracked by Wall St. Rank held Incyte as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.